Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online June 26, 2019.
Copyright & Usage
Copyright © 2019 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.
Author Information
- Gohar Fakhfouri1,
- Reza Rahimian1,
- Jonas Dyhrfjeld-Johnsen,
- Mohammad Reza Zirak, and
- Jean-Martin Beaulieu
- Department of Psychiatry and Neuroscience, Faculty of Medicine, CERVO Brain Research Centre, Laval University, Quebec, Quebec, Canada (G.F., R.R.); Sensorion SA, Montpellier, France (J.D.-J.); Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran (M.R.Z.); and Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada (J.-M.B.)
- Jeffrey M. Witkin, ASSOCIATE EDITOR
- Address correspondence to:
Dr. Jean-Martin Beaulieu, Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Medical Science Building, Toronto, ON M5S 1A8, Canada. E-mail: martin.beaulieu{at}utoronto.ca
Statistics from Altmetric.com
Article usage
In this issue
5-HT3 Receptor Antagonists in Neurology and Neuropsychiatry
Jump to section
- Article
- Abstract
- I. Introduction
- II. 5-HT3 Receptor Structure, Distribution, and Ligands
- III. Biologic Effects of 5-HT3 Receptor Antagonists, a Final Remark
- IV. 5-HT3 Receptor Antagonists in Neurologic Disorders
- V. 5-HT3 Receptor Antagonists in Psychiatric Disorders
- VI. Concluding Remarks
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters